Holders — by stockHoldings — by fund
Caligan Partners LP
Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-06-30 · filed with the SEC up to 45 days after quarter end · CIK 0001727492
$2.13B
disclosed book value
26
positions
30.5%
largest position share
Positions, as of 2026-06-30
top 28 of 26 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | LQDALIQUIDIA CORPORATION | 8.1M | $647.3M | 30.5% |
| 2 | RVMDREVOLUTION MEDICINES INC | 2.0M | $367.4M | 17.3% |
| 3 | ABVXABIVAX SA | 1.6M | $207.6M | 9.8% |
| 4 | PCVXVAXCYTE INC | 2.2M | $127.2M | 6% |
| 5 | EXELEXELIXIS INC | 1.6M | $84.5M | 4% |
| 6 | TNGXTANGO THERAPEUTICS INC | 2.5M | $78.2M | 3.7% |
| 7 | AVTXAVALO THERAPEUTICS INC | 3.2M | $58.5M | 2.8% |
| 8 | XENEXENON PHARMACEUTICALS INC | 889,944 | $53.7M | 2.5% |
| 9 | ADMAADMA BIOLOGICS INC | 5.7M | $47.9M | 2.3% |
| 10 | RVMDREVOLUTION MEDICINES INCCALL | 251,800 | $47.2M | 2.2% |
| 11 | LBRXLB PHARMACEUTICALS INC | 1.4M | $46.7M | 2.2% |
| 12 | IMCRIMMUNOCORE HLDGS PLC | 1.4M | $43.9M | 2.1% |
| 13 | VRDNVIRIDIAN THERAPEUTICS INC | 2.2M | $40.3M | 1.9% |
| 14 | VORVOR BIOPHARMA INC | 1.9M | $35.4M | 1.7% |
| 15 | SABSSAB BIOTHERAPEUTICS INC | 8.0M | $31.1M | 1.5% |
| 16 | IVAINVENTIVA SA | 8.2M | $30.9M | 1.5% |
| 17 | AURAAURA BIOSCIENCES INC | 4.3M | $30.5M | 1.4% |
| 18 | TYRATYRA BIOSCIENCES INC | 806,986 | $25.8M | 1.2% |
| 19 | IRDOPUS GENETICS INC | 6.1M | $25.0M | 1.2% |
| 20 | ANIKANIKA THERAPEUTICS INC | 1.4M | $21.0M | 1% |
| 21 | SGMTSAGIMET BIOSCIENCES INC | 2.5M | $19.3M | 0.9% |
| 22 | ARTVARTIVA BIOTHERAPEUTICS INC | 1.7M | $16.8M | 0.8% |
| 23 | FTHFAETH THERAPEUTICS INC | 629,467 | $15.7M | 0.7% |
| 24 | MBXMBX BIOSCIENCES INC | 200,000 | $11.0M | 0.5% |
| 25 | VRCAVERRICA PHARMACEUTICALS INC | 923,910 | $5.7M | 0.3% |
| 26 | AGIOAGIOS PHARMACEUTICALS INCCALL | 90,000 | $3.3M | 0.2% |
| 27 | ADMAADMA BIOLOGICS INCCALL | 300,000 | $2.5M | 0.1% |
| 28 | CLRBCELLECTAR BIOSCIENCES INC | 469,998 | $1.3M | 0.1% |
Source: SEC Form 13F-HR, reporting period 2026-06-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.